Welcome back to our blog series on National Member News!

We are excited about getting our National Member news out to the world, so more people can find out what it is happening in each country and each member organisation! We caught up with David Kříž from the Lupus Group of Revma Liga Česká Republika, who talked to us about the fantastic work the organisation is doing, the needs of lupus patients in the Czech Republic and much more!

 

How do you keep in touch with your members?

We stay in touch with the members of Revma Liga ČR through regular newsletters, emails, social media, and our website. We also organize meetings, events, and professional seminars where members can engage and share their experiences.

 

Did you have any special meetings or webinars during the past year (World Lupus Day, Rare Disease Day, Annual General Meeting, etc.)?

Yes, in the past year we focused on events such as World Arthritis Day and other awareness campaigns related to rheumatic diseases. We hosted webinars, recorded several videos, and organised meetings where we shared up-to-date information on treatment and prevention.

 

Have there been any circumstances during the pandemic that changed the way of living with lupus?

The pandemic brought increased stress and isolation, which affected patients with rheumatic diseases, including lupus. Many of our members had limited access to medical care and physiotherapy, which increased the need for digital health services and virtual support.

 

Has Digital Health improved or changed in your country?

Not significantly. Although the pandemic accelerated the use of digital health, for instance through telemedicine, there is still a lack of a comprehensive approach to the issue. Our organization is working hard to support this topic and is showing the way through its activities.

 

What kind of support would you most need in your country for lupus?

We most need to raise awareness of lupus among the public and healthcare professionals. We would also appreciate greater availability of specialised centres focusing on lupus, and mental health support for patients.

 

Is there anything you think Lupus Europe could help your organisation with?

Lupus Europe could help us by sharing international experiences and best practices in the treatment of lupus. Collaboration on campaigns and exchanging information could increase awareness of this disease in the Czech Republic as well.

 

Is there any topic/area you think Lupus Europe should focus on, or where European collaboration would make sense?

European collaboration would make sense in the research of new treatments and increasing the availability of innovative drugs. Joint campaigns aimed at raising awareness and early diagnosis of lupus would also be highly valuable.

 

Are you aware of the Lupus Europe Member Capacity Building Program?

Yes, we are aware of the program and see it as a great opportunity for the development of our organisation, as well as for sharing experiences with other member countries.

 

Could you tell us a bit about a dream you have as a group?

Our dream is to ensure that every patient with a rheumatic disease in the Czech Republic has easy access to the latest treatments and expert care. We also want to raise public awareness of these diseases and ensure a better quality of life for all patients.

 

Live Facebook Feed

Comments Box SVG iconsUsed for the like, share, comment, and reaction icons

We are very proud to share that LupusGPT has now been published in The Lancet Rheumatology, one of the world’s leading medical journals in rheumatology.

For us, this is not only about a publication. It is about what LupusGPT stands for.

LupusGPT is free. It is patient-led. And it was built to help people living with lupus find reliable, accessible information in almost any language.

It began with a simple but important question: what could become possible if patients, clinicians, and digital experts truly worked together from the start?

That question was first opened up in a fishbowl discussion at the European Lupus Meeting 2024 on how the lupus community could get the best, but not the worst, out of AI. From there, LupusGPT was shaped through the care, intelligence, and effort of many people: volunteers, patient testers, clinicians testing across languages, people who gave feedback, and people already helping us share it with patients in clinics, organisations, and communities.

This publication matters because it shows that patient-led innovation belongs in the scientific world too. It shows that when patient voice is not added at the end, but built in from the start, something real can grow.

A heartfelt thank you to all authors: Zoe Karakikla-Mitsakou, Alain Cornet, Jeanette Andersen, Sarah Dyball, Cristiana Sieiro Santos, Daniel Guimarães de Oliveira, and Laurent Arnaud. Special thanks also to Daniel Guimarães de Oliveira for the thought, care, and belief he brought to this work, and to Professor Laurent Arnaud for his outstanding support, steadiness, and guidance.

And above all, thank you to everyone in the Lupus Europe community who keeps showing us why this matters.

LupusGPT. Free. Multilingual. Patient-led. And now part of the scientific record.

doi.org/10.1016/S2665-9913(25)00370-4

Read it for free now! You only need to register (registration is completely free and takes 1')
... See MoreSee Less

We are very proud to

🚨 Today is #WORDDAY2026! Which stands for WOrld Young Rheumatic Disease Day.

🌍 Through this global event, we can spread the word that children and young people get rheumatic diseases like lupus, too.

‼️ It is estimated that around 15-20% of #lupus patients are children, although it is rare that a child develops lupus before 5 years of age.

As with adult patients, the cause of lupus remains unknown, and there is a great choice of treatments to keep the disease under control.

🔴 On average, it takes nearly 6 years for people with lupus to be diagnosed. This delay in diagnosis, and therefore in treatment, can have an impact on the prognosis and quality of life of patients; this includes kids.

😰 The moment your child gets a diagnosis might be overwhelming for you. This feeling of overwhelm can and does go away with time and with access to the right information.

👉 Remember: it is impossible to learn everything about #lupus overnight! Your child's doctor is the best source of information.

Apart from pharmacological treatment, other non-pharmacological measures can also help in lupus management.

📷 Take a look at the images we are sharing today to learn about these non-pharmacological measures and share them with your community to help us raise awareness.

🐺 Lupus can seem scary at first. Remember that you are not alone and that you are going to do a great job!

Turn to your lupus association for support.

🤗 There are many organisations across Europe that can help you and your child cope with the disease.

More information on #SLE in children at #Lupus100: f.mtr.cool/oklkpqamyu

For more information on WORD Day, you can visit World Young Rheumatic Diseases Day - WORD Day
... See MoreSee Less

Image attachment
Image attachment
Image attachment
Image attachment
Image attachment

🔴 Tomorrow is #WORDDAY2026!

🦋 And we will be sharing tips and information on how #lupus can affect children.

Help us raise awareness, which is key for an early diagnosis & a quick referral to a specialised paediatric rheumatologist.

Share our posts and follow the World Young Rheumatic Diseases Day - WORD Day campaign.

More information on lupus in children at #Lupus100 (19 languages):

f.mtr.cool/hnfukbkwdf
... See MoreSee Less

🔴 Tomorrow is #WO

Watch this Lupus Europe Webinar on the European Lupus Meeting (ELM) 2026, As Viewed by Lupus Europe's PAN Members & Volunteers!

... See MoreSee Less

0 CommentsComment on Facebook

LUPUS EUROPE Uniting people with Lupus throughout Europe
Send